Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates
- 7 December 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 65 (24) , 16234-16251
Abstract
With the emergence and rapid spreading of NDM-1 and existence of clinically relevant VIM-1 and IMP-1, discovery of pan inhibitors targeting metallo-beta-lactamases (MBLs) became critical in our battle against bacterial infection. Concurrent with our fragment and high-throughput screenings, we performed a knowledge-based search of known metallo-beta-lactamase inhibitors (MBLIs) to identify starting points for early engagement of medicinal chemistry. A class of compounds exemplified by 11, discovered earlier as B. fragilis metallo-beta-lactamase inhibitors, was selected for in silico virtual screening. From these efforts, compound 12 was identified with activity against NDM-1 only. Initial exploration on metal binding design followed by structure-guided optimization led to the discovery of a series of compounds represented by 23 with a pan MBL inhibition profile. In in vivo studies, compound 23 in combination with imipenem (IPM) robustly lowered the bacterial burden in a murine infection model and became the lead for the invention of MBLI clinical candidates.Keywords
This publication has 47 references indexed in Scilit:
- A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011Pharmaceuticals, 2013
- Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitorProceedings of the National Academy of Sciences, 2012
- Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712Bioorganic & Medicinal Chemistry Letters, 2011
- Biochemical and Structural Characterization of the Subclass B1 Metallo-β-Lactamase VIM-4Antimicrobial Agents and Chemotherapy, 2011
- NH-1,2,3-Triazole Inhibitors of the VIM-2 Metallo-β-LactamaseACS Medicinal Chemistry Letters, 2010
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Clavulanic acid: A reviewBiotechnology Advances, 2008
- Structural basis for the broad-spectrum inhibition of metallo-β-lactamases by thiolsOrganic & Biomolecular Chemistry, 2008
- A chemical method for fast and sensitive detection of DNA synthesis in vivoProceedings of the National Academy of Sciences, 2008
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug DiscoveryJournal of Medicinal Chemistry, 2008